Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cervical Cancer × toripalimab × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 10 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Melanoma 2 Gestational Trophoblastic Disease 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Recurrence 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Head and Neck Neoplasms 1 Advanced Cervical Cancer 1

Interventions

Paclitaxel 2 Cisplatin 2 Carboplatin 2 toripalimab 1 sintilimab 1 camrelizumab 1 anlotinib 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04731038 2021-09-17

Combination Therapy for First Line Treatment of Advanced Cervical Cancer

Ruijin Hospital

Phase 1 Unknown

Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡